Remidio

Team Remidio is excited to be at the world's largest ophthalmology conference at McCormick Place in Chicago! AAO 2024, the annual conference hosted by the American Academy of Ophthalmology, attracts over 13,000 eye care professionals from around the world. With a range of easy-to-use innovative solutions that prevent blindness and preserve vision, Team Remidio is eagerly looking forward to doing what we do best – talking science! If you are attending hashtag#AAO2024, please visit us at booth 1935 between October 18 - 21 and join in our discussions. Anand Sivaraman Divya Rao Erik Hafkey Eran Livneh #Remidio #AAO2024 #ophthalmology #ophthalmicintelligence #innovation #medtech #eyecare #chicago

Remidio is all set to connect with global digital health enthusiasts at this year's Digital Health Summit at Jio World Convention Centre, Mumbai. Join Remidio’s Anand Sivaraman as he shares valuable insights in his talk, Screenings & Diagnostics in the Digital Age, alongside fellow industry experts. The summit, themed Digital Health at Scale: Success Stories, will bring together nearly 2,000 leaders, innovators, and solution providers from around the world to shape the future direction of healthcare. Remidio is proud to contribute to this important conversation and help drive progress in the digital health space. Global Digital Health Summit, Expo & Innovation Awards #remidio #digitalhealthsummit #screening #diagnostics #AI #artificialintelligence #mumbai

Celebrating the 155th birth anniversary of Mahatma Gandhi, a uniquely bespectacled man whose vision continues to strengthen and unite communities worldwide! His birthday also marks the International Day of Non-Violence. Happy Gandhi Jayanthi from Team Remidio! Let the peace be with you. #remidio #gandhijayanthi #mahatma #nonviolence #equality #togetherness

At Remidio, we celebrate a vibrant workplace where boldness, openness, and dynamism thrive—not just in innovation but also in team activities! Our recent Table Tennis Tournament - 2024 showcased this spirit, bringing colleagues together for a day of fun, friendly competition, and unforgettable moments. From thrilling matches to enthusiastic cheers, this year’s tournament highlighted the camaraderie and sportsmanship that make Remidio exceptional. Join us in celebrating these highlights and discover why Remidio is more than just a workplace—it's a community. Are you ready to be part of a team that values hard work and play? Connect with Team Remidio today! #remidio #bold #open #dynamic #collaboration #funatwork #teamwork #collaboration

"Healthy aging is about thriving, not just adding years to life." This Healthy Aging month, Team Remidio took a proactive approach by offering vision screenings to employees and their families aged 40 and above. Why does this matter? Eye health often goes unnoticed until significant problems arise, especially among older adults who may neglect early signs to avoid burdening loved ones. Early detection of issues like cataracts, glaucoma, and macular degeneration can greatly improve quality of life and preserving vision. By focusing on eye health, we are fostering a culture of well-being and empowering our team and their loved ones for a brighter tomorrow. Stay tuned to hear their stories and explore the benefits of early screenings! Dr Kalpa Negiloni Ranjitha K Shreya A Bhandary jyoti mundhra #remidio #glaucoma #diabeticretinopathy #cataract #maculadegeneration #healthyagingmonth #vision #screening

Over 400 eye care professionals from 83 countries explored the role of fundus imaging and AI in diagnosing posterior segment pathology. They focused on the crucial aspects of validation, evaluation, and real-world implementation of AI technologies. AI-powered screening for glaucoma and diabetic retinopathy significantly improves early detection in underserved regions. In the latest Remidio Orbis Cybersight webinar, three industry experts discussed the development and Implementation of AI in eye care across the globe. Some of the questions asked includes: 1. What is the role of pachymetry in glaucoma diagnosis and management? 2. What percentage of diabetic patients develop diabetic retinopathy? 3. Where does diabetic retinopathy rank as a cause of blindness in the working population? 4. Can we integrate glaucoma screening into existing AI diabetic retinopathy programs to improve accessibility and reduce costs? Discover impactful insights, success stories, and challenges on https://lnkd.in/gTQ9C93E Dr Andrzej Grzybowski Dr Yih Chung Tham 覃宇宗 #remidio #glaucoma #AMD #ROPAI #Diabeticretinopathy #cybersight #orbis #webinar #fundus #posteriorsegment #AI #artificialInteliigence

Dr. Kalpa Negiloni, Deputy Head of Clinical Research at Remidio, will speak at the "IVI-IOA Virtual Entrepreneurship Summit" on 28th September. The discussion will cover how digital technology, and telemedicine can transform optometry practices and the evolving role of automated diagnostic tools. The panel will also cover women entrepreneurs, the Make in India movement, healthcare e-commerce, and emerging fields like sports vision and neurorehabilitation. Don't miss this insightful session on the future of eye care! Click here to register: https://zurl.co/3mD7 #remidio #glaucoma #amd #rop #diabeticretinopathy #artificialintelligence #technology #medtech #telemedicine #healthcare #ophathlomologist #optometrist

What's new? With Central Drugs Standard Control Organization' s(CDSCO) approval of Remidio's DR AI, eye care is revolutionized with a groundbreaking technology which is accessible by anyone, anytime, anywhere! Hear from Dr. Rengaraj Venkatesh, Chief Medical Officer at Aravind Eye Hospital, as he shares his thoughts on this innovative technology. #remidio #CDSCO #ophthalicAI #diabeticretinopathy #vision #screening #mediosAI #eyecare #medtech

AI can ensure accurate diagnoses across diverse populations. Presenting this week’s publication for our throwbackthursday series: “Diabetic Retinopathy Screening Using Smartphone-Based Fundus Photography and Deep-Learning Artificial Intelligence in the Yucatan Peninsula: A Field Study” In this study, two algorithms—Medios AI, trained on multi-ethnic datasets, and EyeArt, trained on American and Northern Mexican patients—demonstrated high sensitivity and specificity, despite their different training methodologies. Through our #throwbackthursday series, every fortnightly Team Remidio will celebrate one publication from our ever-growing Scientific Compendium of peer-reviewed publications. While we get nostalgic, we also hope to get creative in sharing our science with you! #remidio #glaucom #diabeticretinopathy #ropai #publication #science #retina #fop #AI #imagequality #handheld #portable #screening #visionwellness

"With growing awareness and trust in AI, doctors are now more eager than ever to implement these cutting-edge solutions in their clinics," shares Team Remidio’s Saurabh Darda after engaging diabetologists, endocrinologists, and diabetes experts at the European Association for the Study of Diabetes e.V. (EASD) 2024. The instant patient report generated by Remidio's FOP NM 10 in less than 10 seconds wowed all attendees who are keen on advancing diabetes care for their patients. #remidio #diabeticretinopathy #artificialintelligence #AI #diabetes #diabetescare #EASD2024 #madrid #europe